PT Kalbe Farma Tbk.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTKFF research report →
About the company
Indonesia-based pharmaceutical powerhouse, PT Kalbe Farma Tbk. , along with its affiliated companies, is engaged in the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical products throughout the country. The organization structures its operations across four primary business units: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic.
- CEO
- Bernadette Ruth Irawati Setiady
- IPO
- 2002
- Employees
- 12,841
- HQ
- Jakarta, ID
Price Chart
- Market Cap
- $1.82B
- P/E
- 9.41
- P/S
- 0.94
- P/B
- 1.40
- EV/EBITDA
- 5.66
- Div Yield
- 2.67%
- Gross Margin
- 38.67%
- Op Margin
- 12.30%
- Net Margin
- 10.00%
- ROE
- 15.56%
- ROIC
- 13.15%
- Revenue
- $35.32T · 8.27%
- Net Income
- $3.66T · 13.10%
- EPS
- $80.51 · 14.65%
- Op Income
- $4.55T
- FCF YoY
- -30.38%
- 52W High
- $0.10
- 52W Low
- $0.04
- 50D MA
- $0.05
- 200D MA
- $0.06
- Beta
- -0.04
- Avg Volume
- 2.30K
Get TickerSpark's AI analysis on PTKFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PTKFF coverage
Recent articles, reports, and earnings notes.
No research on PTKFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PTKFF report →Similar companies
Peers in the same neighborhood.